The Hemodynamic Effects of an SGLT2 Inhibitor in Heart Failure with Preserved Ejection Fraction.Published in:Clinical Cardiology Alert, 2023, v. 42, n. 10, p. 1Publication type:Article
An RNA Shot for Hypertension?Published in:Clinical Cardiology Alert, 2023, v. 42, n. 10, p. 1Publication type:Article
Is the Combination of a GLP-1 Agonist and a SGLT2 Inhibitor Safe?Published in:Clinical Cardiology Alert, 2023, v. 42, n. 10, p. 1Publication type:Article
Is Planned Complete Revascularization After Myocardial Infarction Wise for Older Patients?Published in:Clinical Cardiology Alert, 2023, v. 42, n. 10, p. 1Publication type:Article
High-Impact Clinical Trials from the European Society of Cardiology Congress 2023.Published in:Clinical Cardiology Alert, 2023, v. 42, n. 10, p. 1Publication type:Article